Silver Fern

Silver Fern is offering a paid graduate IT internship this autumn/ winter.

Click here for more details.

Welcome to the latest edition of our newsletter, including an overview of the current state of genetic medicine, tips for cynical travellers and exciting news from the Silver Fern pond.

Click here to read

Errol Crosbie was one of the judging panel for the BOBI Challenge Day on 15th March. A second Silver Ferner, Ewa Roope, was one of the judges for the Best Newcomer Day on 7th March.

Congratulations to Ewan Crosbie who has been promoted to Senior Research Executive and to Selina Wang who has been promoted to Research Support Executive. Both richly deserved.

As the year draws to a close, we would like to wish every one of our clients, suppliers and friends a very Happy Christmas and an exciting and prosperous New Year.

Thank you all for your support and assistance in 2010, we very much look forward to working with you in 2011

Click here to read

William Russell has joined Silver Fern as a Research Director. Until recently, he headed up the full service division of another healthcare agency, but felt that the time had come to take up a new challenge. “I am really excited about Silver Fern’s 2011 objectives and the part I will play in meeting them” he says.

William has a strong scientific background, having studied Biological Sciences and Toxicology to PhD level. After working on vaccines, diagnostics and eye disease in research laboratories and at St Thomas’ Hospital, he made the move to Healthcare Market Research, where he has specialised in Qual and KOL work throughout Europe, the USA, Canada, Latin & Central America. Having particular expertise in Cardiology, CNS, gastroenterology, infectious diseases, metabolic disorders, oncology, ophthalmology and respiratory disease, William will be add further depth to Silver Fern’s research team and take our ‘medicalisation’ programme even further forward

As most of you know, Silver Fern has been at the forefront of pharmaceutical market research for nearly thirty years now, but that doesn’t mean we can afford to rest on our laurels. We've launched our new website and introduced new ideas and techniques. We’ll soon be introducing new faces and now here is the first edition of our brand new communications campaign. We hope you like it.

Click here to read

Health Minister, Andrew Lansley’s White Paper, back in July outlining the government’s plans for the NHS, caused shockwaves in an industry which is still adapting to the growth in influence of PCTs. At first glance the proposals looked like a u-turn to the old days of bottom-up decision making and the resurgence of detail-lead sales teams. However, a closer reading revealed a more complex picture.

Click here to read the full article

Silver Fern is taking part in a BHBIA initiative to measure the impact of the revised ABPI/BHBIA Adverse Event Reporting Guidelines on the industry. We will be collating data on the volume and context of Adverse Event reports over a ten week period. The aim is to create a database of the number and type of AEs reported, the format of the reports, the context of an individual patient verses a group of patients, and the consent rate for contact/follow up by Drug Safety. Clients can rest assured that the information collected will not contain any personal data, nor any confidential information about their company - the database will be used solely for the analysis purposes by the BHBIA AE Reporting in Market Research Task Force as part of their feedback process.

The first phase of the office refurbishment has been completed and staff have moved into their newly renovated offices.

“We have settled well into our new surroundings and are already seeing the benefit of a much improved environment and better facilities” says Silver Fern’s Research Manager, Alison Williams. “This will help us to deliver the best possible service to our clients”.

Silver Fern Research announces the appointment of an additional Research Director to their research team. Currently heading up the full service division of another healthcare agency, Dr X will assume his duties from November 2010.

“He brings a unique blend of skills and experience that combines top class scientific credentials with successful delivery of international qualitative research projects” says Silver Fern’s General Manager, David Robinson. “We are delighted to have obtained the services of such an enthusiastic and experienced researcher”.

Silver Fern Research is pleased to announce the strengthening of their global field network, with the addition of a new alliance partner; GKA who bring extra depth and coverage to the UK segment of Silver Fern’s international projects.

GKA’s full CATI capability also enhances Silver Fern’s rapid-turnaround, Phase II service designed to support in-licensing decisions with in-depth market assessments delivered in very short timelines.

“We have worked informally with GKA over the years and have always been more than happy with their support and responsiveness,” said Errol Crosbie, MD of Silver Fern. “We are delighted that they have now chosen to add their strengths to those of our other worldwide partners.”

Silver Fern’s growing alliance network brings together the best of the world’s fieldwork providers across five continents. “Standardised working practices and a common set of goals mean that no matter where or what our clients need to research, we have a team in place, ready to deliver.”